title: Rhabdomyolysis in a patient treated with linezolid for extensively drug-resistant tuberculosis.
authors.affiliation: Tuberculosis Research Section, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland, USA.
authors.forename: Matthew W
authors.initials: MW
authors.lastname: Carroll
authors.forename: Hongjo
authors.initials: H
authors.lastname: Choi
authors.forename: Seonyeong
authors.initials: S
authors.lastname: Min
authors.forename: Soohee
authors.initials: S
authors.lastname: Hwang
authors.forename: Hyeeun
authors.initials: H
authors.lastname: Park
authors.forename: Taeksun
authors.initials: T
authors.lastname: Song
authors.forename: Yumi
authors.initials: Y
authors.lastname: Park
authors.forename: Han-Seung
authors.initials: HS
authors.lastname: Jeon
authors.forename: Lisa C
authors.initials: LC
authors.lastname: Goldfeder
authors.forename: Laura E
authors.initials: LE
authors.lastname: Via
authors.forename: Janette
authors.initials: J
authors.lastname: Lebron
authors.forename: Boyoung
authors.initials: B
authors.lastname: Jin
authors.forename: Ying
authors.initials: Y
authors.lastname: Cai
authors.forename: Clifton E
authors.initials: CE
authors.lastname: Barry
authors.forename: Myungsun
authors.initials: M
authors.lastname: Lee
mesh_terms: D000081:Acetamides / Q000008:administration & dosage* / Q000009:adverse effects*; D000328:Adult; D000995:Antitubercular Agents / Q000008:administration & dosage* / Q000009:adverse effects*; D054908:Extensively Drug-Resistant Tuberculosis / Q000188:drug therapy*; D006801:Humans; D000069349:Linezolid; D008297:Male; D023303:Oxazolidinones / Q000008:administration & dosage* / Q000009:adverse effects*; D012206:Rhabdomyolysis / Q000139:chemically induced* / Q000473:pathology
chemical_list: D000081:Acetamides; D000995:Antitubercular Agents; D023303:Oxazolidinones; D000069349:Linezolid